| Dr Nada El Andary, MD | |
|
1000 East Mtn Blvd, Wilkes Barre, PA 18711-0027 | |
| (570) 808-6026 | |
| (570) 808-3208 |
| Full Name | Dr Nada El Andary |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 22 Years |
| Location | 1000 East Mtn Blvd, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053500470 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Geisinger-lewistown Hospital | Lewistown, PA | Hospital |
| Geisinger Jersey Shore Hospital | Jersey shore, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
| Evangelical Medical Services Organization | 9133033087 | 229 |
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
Eating yogurt on a regular basis does not necessarily improve health-related quality of life, report Spanish researchers...
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
› Verified 9 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Eating yogurt on a regular basis does not necessarily improve health-related quality of life, report Spanish researchers...
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
› Verified 9 days ago
| Entity Name | Evangelical Medical Services Organization |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295834984 PECOS PAC ID: 9133033087 Enrollment ID: O20040310000212 |
News Archive
Eating yogurt on a regular basis does not necessarily improve health-related quality of life, report Spanish researchers...
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
› Verified 9 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
Eating yogurt on a regular basis does not necessarily improve health-related quality of life, report Spanish researchers...
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nada El Andary, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Nada El Andary, MD 1000 East Mtn Blvd, Wilkes Barre, PA 18711-0027 Ph: (570) 808-6026 |
News Archive
Eating yogurt on a regular basis does not necessarily improve health-related quality of life, report Spanish researchers...
According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
› Verified 9 days ago
Dr. Richard M. Somma, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-820-6028 Fax: 570-826-7943 | |
Dr. Mitchell J. Gross, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-820-6028 Fax: 570-826-7943 | |
Dr. Francisco Santos, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1111 E End Blvd, Wilkes Barre, PA 18711 Phone: 570-824-3521 Fax: 570-819-5147 | |
Elmyra V. Encarnacion, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-6026 Fax: 570-808-3208 | |
Yasser M Khorchid, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7300 Fax: 570-808-3208 | |
Holly Marie Drutarovsky, PA-C Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7300 |